The Recall Desk

Manufacturer

Cardinal Health Inc.

240 recalls in our database name Cardinal Health Inc. as the manufacturing or recalling firm.

What the numbers show

Total
240
Critical
2
Severe
8
Most recent
2025-09-03

Of the 240 recalls from Cardinal Health Inc. we have scored against our rubric, 2 (1%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 8 (3%) are Severe.

Which agencies issued them

About this listing

The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.

Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.

51–75 of 240

  • ModerateFDA (Drugs)·D-0508-2021·2021-06-02

    Cardinal Health Recalls TRI-LO-MARZIA Due to Temperature Excursions

    Cardinal Health is recalling 60 cartons of TRI-LO-MARZIA oral contraceptives distributed in Florida, Georgia, and South Carolina due to intermittent temperature excursions during storage.

    Product
    TRI-LO-MARZIA — TRI-LO-MARZIA (NORGESTIMATE AND ETHINYL ESTRADIOL)
    Category
    Drug
    Distribution
    3 states
  • ModerateFDA (Drugs)·D-0441-2021·2021-06-02

    Cardinal Health Recalls Eszopiclone Tablets Due to Temperature Excursions

    Cardinal Health is recalling 29 bottles of Eszopiclone 3mg tablets due to intermittent temperature exposure during storage. The product was distributed in Florida, Georgia, and South Carolina.

    Product
    ESZOPICLONE 3MG 100 C4; NDC/UPC 65862096901; RX; TABLETS
    Category
    Drug
    Distribution
    3 states
  • ModerateFDA (Drugs)·D-0530-2021·2021-06-02

    Cardinal Health Recalls Vitamin D3 Tablets Due to Temperature Excursions

    Cardinal Health Inc. is recalling 47 bottles of NAT B VIT D3 2000U tablets due to intermittent exposure to temperature excursions during storage.

    Product
    NAT B VIT D3 2000U 100; NDC/UPC 079854041125; OTC; TABLETS
    Category
    Drug
    Distribution
    3 states
  • ModerateFDA (Drugs)·D-0479-2021·2021-06-02

    Cardinal Health Recalls Arnuity Ellipta Inhalers Due to Temperature Excursions

    Cardinal Health Inc. is recalling 513 Arnuity Ellipta inhalers distributed in Florida, Georgia, and South Carolina due to intermittent exposure to temperature excursions during storage.

    Product
    ARNUITY ELLIPTA 100MCG 30INH; NDC/UPC 173087410; RX; INHALER MEDICAL INTERNAL - MAY OR MAY NOT BE AEROSOL
    Category
    Drug
    Distribution
    3 states
  • ModerateFDA (Drugs)·D-0426-2021·2021-06-02

    Cardinal Health Recalls Enoxaparin Syringes Due to Temperature Excursions

    Cardinal Health is recalling 64 boxes of Enoxaparin Dofium Injection 150mg/1ml syringes due to intermittent temperature excursions during storage.

    Product
    ENOXAPARIN DOFIUM INJRVYION, UPD 150MG/1ML 10X1ML SINGLE DOSE SYRINGES; NDC/UPC 60505-0798-4; RX; SYRINGES
    Category
    Drug
    Distribution
    3 states
  • ModerateFDA (Drugs)·D-0533-2021·2021-06-02

    Cardinal Health Recalls Tobrex Ointment Due to Temperature Excursions

    Cardinal Health Inc. is recalling 28 tubes of Tobrex 0.3% Ophthalmic Ointment due to intermittent exposure to temperature excursions during storage.

    Product
    TOBREX 0.3% 3.5GM OPTH; NDC/UPC 65064435; RX; OINTMENT
    Category
    Drug
    Distribution
    3 states
  • ModerateFDA (Drugs)·D-0516-2021·2021-06-02

    Cardinal Health Recalls Vitamin D3 Tablets Due to Temperature Excursions

    Cardinal Health Inc. is recalling 19 bottles of Vitamin D3 25mcg tablets because they were intermittently exposed to temperature excursions during storage.

    Product
    VITAMIN D3 25MCG 180 TABLETS; NDC/UPC 880681168011; OTC; TABLETS
    Category
    Drug
    Distribution
    3 states
  • ModerateFDA (Drugs)·D-0482-2021·2021-06-02

    Cardinal Health Recalls Trelegy Ellipta Inhalers Due to Temperature Excursions

    Cardinal Health is recalling 903 Trelegy Ellipta inhalers distributed in Florida, Georgia, and South Carolina due to intermittent exposure to temperature excursions during storage.

    Product
    TRELEGY ELLIPTA — TRELEGY ELLIPTA (FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE)
    Category
    Drug
    Distribution
    3 states
  • ModerateFDA (Drugs)·D-0414-2021·2021-06-02

    Cardinal Health Recalls Vaniqa Cream Due to Temperature Excursions

    Cardinal Health is recalling 72 tubes of Vaniqa cream distributed in Florida, Georgia, and South Carolina due to intermittent temperature excursions during storage.

    Product
    Vaniqa (eflornithine hydrochloride) Cream, 13.9% For Topical Use Only Net wt. 1.59 oz (45 g) Rx only NDC 0023-4857-45 Manufactured for Allegan, Inc. Irvine, CA 92612
    Category
    Drug
    Distribution
    3 states
  • ModerateFDA (Drugs)·D-0589-2021·2021-06-02

    Cardinal Health Recalls VIMPAT Tablets Due to Temperature Excursions

    Cardinal Health Inc. is recalling 796 bottles of VIMPAT (lacosamide) 100 mg tablets due to intermittent temperature excursions during storage.

    Product
    VIMPAT(lacosamide) Tablets ,100 mg, 60-count bottle; Rx Only, Manufactured for: UCB, Inc. Smyrna, GA 30080
    Category
    Drug
    Distribution
    3 states
  • ModerateFDA (Drugs)·D-0525-2021·2021-06-02

    Cardinal Health Recalls Asmanex Twistero Inhalers Due to Temperature Excursions

    Cardinal Health is recalling 122 Asmanex Twistero inhalers distributed in Florida, Georgia, and South Carolina due to intermittent temperature exposure during storage.

    Product
    ASMANEX TWST 220MCG 60INH PWD; NDC/UPC 85134102; RX; INHALER MEDICAL INTERNAL - MAY OR MAY NOT BE AEROSOL
    Category
    Drug
    Distribution
    3 states
  • ModerateFDA (Drugs)·D-0515-2021·2021-06-02

    Cardinal Health Recalls Vitamin D3 Tablets Due to Temperature Excursions

    Cardinal Health Inc. is recalling 53 bottles of Vitamin D3 25mcg tablets due to intermittent exposure to temperature excursions during storage.

    Product
    VITAMIN D3 25MCG 90 TABLETS; NDC/UPC 880681168004; OTC; TABLETS
    Category
    Drug
    Distribution
    3 states
  • ModerateFDA (Drugs)·D-0410-2021·2021-06-02

    Cardinal Health Recalls Atropine Sulfate Ophthalmic Solution Due to Temperature Excursions

    Cardinal Health Inc. is recalling 424 bottles of Atropine Sulfate Ophthalmic Solution 1% due to intermittent temperature excursions during storage.

    Product
    Atropine Sulfate Ophthalmic Solution, USP 1% For Topical Application To The Eye Sterile 5 mL Rx only NDC 17478-215-05 Manufactured by: Akorn, Inc.
    Category
    Drug
    Distribution
    3 states
  • ModerateFDA (Drugs)·D-0546-2021·2021-06-02

    Cardinal Health Recalls Fexofenadine Tablets Due to Temperature Excursions

    Cardinal Health is recalling 321 bottles of Fexofenadine Hydrochloride 180 mg tablets due to intermittent temperature excursions during storage. The affected product was distributed in Florida, Georgia, and South Carolina.

    Product
    Fexofenadine Hydrochloride Tablets, 180 mg Antihistamine Non-Drowsy 100 Tablets 180 mg Each NDC 45802-571-78 Distributed By Perrigo Allegan, MI 49010
    Category
    Drug
    Distribution
    3 states

About this company

Community-sourced company facts from Wikidata, not from any recall agency. This is background on the corporate entity — it says nothing about the recall(s) listed on this page, which come from the agency source notice above.

Cardinal Health

Healthcare company

Country
United States
Founded
1971

Official website

Source: Wikidata (Q902397), licensed CC0. Wikidata is community-edited and may not reflect the current corporate structure.